中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:(Shancheng REN)

1.Open radical prostatectomy for locally advanced prostate cancer: report of 132 cases

Fei LIU ; Yue YANG ; Rui CHEN ; Xinwen NIAN ; Ji LYU ; Bo YANG ; Xu GAO ; Jianguo HOU ; Chuanliang XU ; Shancheng REN ; Yinghao SUN

Chinese Journal of Urology 2017;38(6):438-441

2.Robotic-assisted laparoscopic prostatectomy in patients with high-risk prostate cancer :experiences of 400 cases

Min QU ; Hengzhi LIN ; Haifeng WANG ; Linhui WANG ; Bo YANG ; Huamao YE ; Shancheng REN ; Tie ZHOU ; Chuanliang XU ; Yinghao SUN ; Xu GAO

Chinese Journal of Urology 2017;38(6):424-427

3.Application and prospect of artificial intelligence in diagnosis, treatment and prognosis of prostate cancer

Yusi XU ; Rui CHEN ; Yifan CHANG ; Jianglei MA ; Shancheng REN

Chinese Journal of Urology 2023;44(2):152-156

4.Clinical characteristics and treatment strategies of prostate mucinous adenocarcinoma: the multicenter summary of 36 cases

Xiaojun LU ; Yifan CHANG ; Shancheng REN ; Xu GAO ; Lu YANG ; Zhiquan HU ; Chao QIN ; Baijun DONG ; Qiang WEI ; Shaogang WANG ; Zengjun WANG ; Wei XUE ; Yinhao SUN

Chinese Journal of Urology 2018;39(10):721-726

5.Single-port robot-assisted laparoscopic radical prostatectomy through different approaches: initial experience and outcomes

Wei DU ; Weidong XU ; Yue YANG ; Yifan CHANG ; Xiaojun LU ; Yutian XIAO ; Xiaomin ZHANG ; Shi YAN ; Ye WANG ; Zhiyong LIU ; Shancheng REN

Chinese Journal of Urology 2020;41(11):815-819

6.New progress in prostate cancer biomarker research.

Min QU ; Shancheng REN ; Yinghao SUN ; Email: SUNYH@MEDMAIL.COM.CN.

Chinese Journal of Surgery 2015;53(4):317-320

7.Genome-wide association studies on prostate cancer: the end or the beginning?

Rui CHEN ; Shancheng REN ; Yinghao SUN

Protein & Cell 2013;4(9):677-686

8.Progress of neoadjuvant therapy for high-risk prostate cancer in the era of novel hormonal therapy

Shi YAN ; Yasheng ZHU ; Yutian XIAO ; Tao GUO ; Ye WANG ; Xiaomin ZHANG ; Shancheng REN

Journal of Modern Urology 2023;28(12):1092-1096

9.Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial.

Yifan CHANG ; Xianzhi ZHAO ; Yutian XIAO ; Shi YAN ; Weidong XU ; Ye WANG ; Huojun ZHANG ; Shancheng REN

Frontiers of Medicine 2023;17(2):231-239

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO